COVIDIEN LP for COVIDIEN LP
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues relating to the continued suspension of the medical device tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WHITNEY GARDINER | — |
Health Issues HCR
H.R.6- 21st Century Cures Act- provisions related to medical innovation, technology and medical device regulatory reforms. S.2998/H.R.5009- Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Issues related to Pandemic Preparedness. S.1767- The Combination Product Regulatory Fairness Act- Provisions related to combination products. Education about FDA regulation of hysteroscopic morcellators.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WHITNEY GARDINER | — |
Medicare/Medicaid MMM
Issues related to competitive bidding for DME products. H.R. 5210 and S. 2736- Patient Access to Durable Medical Equipment Act- provisions related to patient access. H.R. 1427/S.804- Medicare CGM Access Act of 2015- Provisions related to continuous glucose monitoring.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WHITNEY GARDINER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.